The study of esophageal cancer risk associated with polymorphisms of DNA damage repair genes XRCC4 and RAD51

Journal of Sichuan University (Medical Science)

Volumn 44, Issue 4, 2013, Pages 568-572

  Fan, Xue Jiao ^a   Ren, Peng Liang ^a   Lu, Zhong Jiao ^a   Zhao, Shu ^a   Yang, Xiao Long ^a   Liu, Ji ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Esophageal cancer; RAD51; Single nucleotide polymorphism; XRCC4

Indexed keywords

DNA BINDING PROTEIN; RAD51 PROTEIN; RAD51 PROTEIN, HUMAN; XRCC4 PROTEIN, HUMAN;

AGED; ARTICLE; CASE CONTROL STUDY; DNA REPAIR; ESOPHAGUS TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; DNA REPAIR; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RAD51 RECOMBINASE;

EID: 84882325998     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Xing D, Tan W, Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep,2003,10(5): 1615-1623.
2. Hiyama T, Yoshihara M, Tanaka S, et al. Genetic polymorphisms and esophageal cancer risk. Int J Cancer,20071 121(8): l643-1658.
3. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev,2002,11(12): 1513-1530.
4. Qiao GB, Wu YL, Yang XN, et al. High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients. Br J Cancer, 20051 93 (1): 137-143.
5. Rollinson S, Smith AG, Allan JM, et al. RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia. Leuk Res,2007,31(2): 169-174.
6. Poplawski T, Arabski M, Kozirowska D, et al. DNA damage and repair in gastric cancer - a correlation with the hOGG1 and RAD51 genes polymorphisms. Mutat Res, 2006,601 (1-2), 83-91.
7. Richardson C, Stark JM, ommundsen M, et al. Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability. Oncogene, 2004, 23 (2): 546-553.
8. Bhatla D, Gerbing RB, Alonzo TA, et al. DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia, a report from the Children's Ontology Group. Leukemia,2008,22(2): 265-272.
9. Sung, P, Klein H. Mechanism of homologous recombination, mediators and helicases take on regulatory functions. Nat Rev Mol Cell Biol,2006,7(10): 739-750.
10. Schwendener S, Raynard S, Paliwal S, et al. Physical interaction of RECQ5 helicase with RAD51 facilitates its anti-Recombinase activity. J Biol Chem, 2010, 285 (21), 15739-15745.
11. Liu Y, Maizels N. Coordinated response of mammalian RadSl and Rad52 to DNA damage. EMBO Rep,2000,1(1), 85-90.
12. Jara L, Acevedo ML, Blanco R, et al. RAD51 135G > C polymorphism and risk of familial breast cancer in a South American population. Cancer Genet Cytogenet, 2007,178 (1), 65-69.
13. Flygare J, Fait S, Ottervald J, et al. Effects of HsRad51 overexpression on cell Proliferation, cell cycle progression, and apoptosis. Exp Cell Res,2001,268(1), 61-69.
14. Raderschell E, Stout K. Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res,2002,62(1): 219-225.